Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation

S Kanda1, J F Bishop, M A Eglitis

  • 1Genetic Pharmacology Unit, Experimental Therapeutics Branch, NINDS, NIH, Bethesda, MD 20892-1406, USA.

Neuroscience
|May 9, 2000
PubMed